𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rapid detection of 3500Q and 3531 mutations and MspI polymorphism in exon 26 at the apolipoprotein B gene

✍ Scribed by Selma A. Cavalli; Mario H. Hirata; Rosario D.C. Hirata

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
71 KB
Volume
15
Category
Article
ISSN
0887-8013

No coin nor oath required. For personal study only.

✦ Synopsis

Several environmental and genetic factors are associated with high levels of cholesterol. Hypercholesterolemia is the main phenotype of Familial Defective Apolipoprotein B and Familial Hypercholesterolemia that are caused by mutations at the apolipoprotein (apo) B and LDL receptor genes, respectively. Identification of the specific genetic alteration associated with hypercholesterolemia is an important issue in clinical diagnosis of high risk for CAD. Apo B gene mutations and polymorphisms are usually screened by SSCP, DGGE, and heteroduplex, which must be confirmed by DNA sequencing or by direct detection using PCR techniques. In this study, we have optimized a PCR-RFLP procedure for identification of 3500Q and 3531 mutations and MspI polymorphism at the apo B gene. The technique can be performed in a single reaction, using the restriction endonuclease MspI for simultaneous detection of 3500Q mutation and MspI polymorphism, and NsiI for detection of 3531 mutation. The procedure was validated by analysis of control DNA samples from individuals carrying these mutations. Screening of 186 Brazilian hypercholesterolemic individuals showed that the frequency of the M-allele (7.8%) of MspI polymorphism was similar to that found in other individuals with CAD. However, neither 3500Q nor 3531 mutations were detected in this group. In conclusion, this procedure is simple and rapid, being easily introduced in clinical laboratories for direct detection of the more frequent mutations at the apo B gene associated with hypercholesterolemia.

📜 SIMILAR VOLUMES

Familial ligand-defective apolipoprotein
Familial ligand-defective apolipoprotein B-100: Simultaneous detection of the ARG3500→GLN and ARG3531→CYS mutations in a French population
✍ JP Rabès; M Varret; B Saint-Jore; D Erlich; G Jondeau; M Krempf; P Giraudet; C J 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

## Communicated by Michel Goossens Familial ligand-defective apolipoprotein B-100 (FDB) is an autosomal dominant disorder leading to plasma LDL cholesterol elevation and coronary artery disease (CAD). Two specific mutations in the APOB gene-R3500Q and R3531C-induce FDB. We report an original metho

Screening for mutations in the exon 26 o
Screening for mutations in the exon 26 of the apolipoprotein B gene in hypercholesterolemic finnish families by the single-strand conformation polymorphism method
✍ Marja Ilmonen; Tiina Heliö; Tapani Ebeling; Kalevi Pyörälä; Matti Uusitupa; Aarn 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 651 KB

To date, the only known apolipoprotein B (apo B) mutation causing hypercholesterolemia is the apo B 3500 Arg Gln or the familial defective apo B (FDB) mutation. This mutation has not been detected in the Finnish population. We have set up a systematic single-strand conformation polymorphism (SSCP) a